Bismuth Subsalicylate Suppliers & Bulk Manufacturers
Available Forms: Oral suspension / Tablet
Available Strengths: 262 mg, 525 mg
Reference Brands: Pepto-Bismol (USA/LATAM),
Category:
Gastrointestinal Drugs
Bismuth Subsalicylate is available in Oral suspension / Tablet
and strengths such as 262 mg, 525 mg.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Bismuth Subsalicylate is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Bismuth Subsalicylate can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Bismuth subsalicylate is a well-established medication widely used for the management of gastrointestinal discomfort and traveler’s diarrhea. It is commonly utilized to relieve symptoms such as upset stomach, nausea, indigestion, heartburn, and mild diarrhea. Due to its protective and antimicrobial properties, the medication helps soothe the lining of the stomach and intestines while also reducing inflammation and limiting the growth of certain bacteria that may contribute to digestive disturbances.
This educational overview highlights the clinical applications of bismuth subsalicylate, including its mechanism of action, pharmacokinetic profile, and appropriate methods of administration. The drug works through multiple mechanisms: it forms a protective coating on the gastrointestinal mucosa, reduces intestinal secretions, and exhibits mild antibacterial activity. These combined effects make it an effective option for short-term management of common digestive complaints, particularly those associated with travel or dietary changes.
Understanding potential adverse reactions and contraindications is an important part of safe use. Healthcare professionals should consider patient-specific factors, including age, medical history, and concurrent medications, when recommending or prescribing this therapy. Proper monitoring and patient guidance can help minimize risks and improve treatment outcomes.
By focusing on evidence-based knowledge and clinical practice considerations, healthcare professionals can use bismuth subsalicylate more effectively. This approach supports informed decision-making, helps optimize dosing strategies, and enables the delivery of safe, individualized care for patients experiencing gastrointestinal symptoms.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing